-
Mashup Score: 0
The direct-acting oral anticoagulant benefitted prevention of adverse clinical events, but was associated with worse major bleeding.
Source: HCPLive®Categories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 6
Your access to the latest cardiovascular news, science, tools and resources.
Source: www.escardio.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#Edoxaban noninferior to #warfarin for adverse events after #heartvalve replacement https://t.co/xRGMlwQt6W #ESCCongress #TAVI #DOACs @Berthacoombs @RealPatCampbell https://t.co/cZgD7lvfPa
-
-
Mashup Score: 0
Antonio Bayés de Luna, MD, FACC, trained as a cardiologist at the University of Barcelona and later studied at the Institute of Cardiology and Hammersmith Hospital in London. He has been a professor since 1971, and accepted the chief of Electrocardiography and Arrhythmic Unit at the Universitat Autonoma de Barcelona in 1990. As president of the World Federation of Cardiology, he founded World…
Source: www.jacc.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
👉 En pacientes seleccionados, una pauta de #edoxaban a dosis bajas puede ser segura, a pesar de un aumento en el riesgo de ictus. 🧐 Descubre en #JACCSpanish @JACCJournals un análisis con implicaciones directas en la práctica clínica del día a día 🆓 https://t.co/VMMLfetT1H https://t.co/wKlwiNAWwU
-
-
Mashup Score: 1
Antonio Bayés de Luna, MD, FACC, trained as a cardiologist at the University of Barcelona and later studied at the Institute of Cardiology and Hammersmith Hospital in London. He has been a professor since 1971, and accepted the chief of Electrocardiography and Arrhythmic Unit at the Universitat Autonoma de Barcelona in 1990. As president of the World Federation of Cardiology, he founded World…
Source: www.jacc.orgCategories: Cardiac Surgery, Latest HeadlinesTweet-
¡Nuevo #JACCSpanish! Selección magnífica de artículos en Español: 📍#TAVI en bajo riesgo a 2 años 📍#Edoxaban a mitad de dosis 📍#Empagliflozina en pts congestivos 📍Rehab . e #IC 📍#Ultraprocesados y enf CV 📍Pronóstico de pts con #IAM evolucionado 🆓 https://t.co/VMMLfetT1H https://t.co/sq7Kg8U9pz
-
-
Mashup Score: 1Carving Out a Niche for Low-Dose Edoxaban in Atrial Fibrillation - 3 year(s) ago
The higher dose remains the standard, but a new ENGAGE AF-TIMI 48 analysis puts the lower dose of the direct oral anticoagulation back in play.
Source: MedscapeCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Practice of low-dosing #edoxaban for AFib explored for risks and benefits. https://t.co/5ROBV0qAkn https://t.co/wOBgCTpJqS
-
-
Mashup Score: 0
Background: Female sex is an independent risk factor for stroke and systemic embolic events in patients with atrial fibrillation. This study aimed to examine the efficacy and safety profile of edoxab
Source: CirculationCategories: Cardiologists, Latest HeadlinesTweet-
"Women in the higher-dose #edoxaban group experienced greater reductions in hemorrhagic #stroke, intracranial bleeding, and fatal bleeding compared to men (P <0.05)." https://t.co/tDX543m3yb
-
-
Mashup Score: 6
Compared with those on a higher dose, patients on a lower-dose edoxaban regimen had lower risk for a composite of stroke, major bleeding and death, according to results published in the Journal of the American College of Cardiology. “In the double-blind, three-arm randomized ENGAGE AF-TIMI 48 trial, both the higher-dose and lower-dose edoxaban regimens, which represent a 50% reduction in
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Compared with those on a higher dose, patients on a lower-dose #edoxaban regimen had lower risk for a composite of #stroke, major bleeding and death @ACCinTouch @SteffelJ @rgiugliano @BrighamWomens @harvardmed @TIMIStudyGroup #Cardiotwitter https://t.co/a0qPfb2kqJ
-
-
Mashup Score: 1
Among women with atrial fibrillation at elevated CV risk, treatment with high-dose edoxaban vs. warfarin conferred greater reduction in hemorrhagic stroke and major bleeding compared with men, with similar efficacy, researchers reported.“The principal findings of this secondary analysis … were that the magnitude of reduction in multiple serious bleeding endpoints with a higher-dose
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Among women with #AFib at elevated CV risk, treatment with high-dose #edoxaban vs. warfarin conferred greater reduction in hemorrhagic #stroke and major bleeding compared with men, with similar efficacy @rgiugliano @BrighamWomens @harvardmed #CardioTwitter https://t.co/1qxebF0CyE
-
-
Mashup Score: 2
Background: Female sex is an independent risk factor for stroke and systemic embolic events in patients with atrial fibrillation. This study aimed to examine the efficacy and safety profile of edoxab
Source: CirculationCategories: Cardiology News and Journals, Latest HeadlinesTweet-
ENGAGE-AF TIMI48 trial sub-study: comparing the efficacy and safety of #edoxaban in women vs. men https://t.co/RlBMoDJIyH #GoRedforWomen #AHAJournals @ZelnikerThomas @rgiugliano @TIMIStudyGroup https://t.co/886WOPrBGW
-
-
Mashup Score: 1NEJM Journal Watch: Summaries of and commentary on original medical and scientific articles from key medical journals - 4 year(s) ago
NEJM Journal Watch reviews over 250 scientific and medical journals to present important clinical research findings and insightful commentary
Source: www.jwatch.orgCategories: Healthcare Professionals, Latest HeadlinesTweet-
Low-Dose #Edoxaban Effective in Elderly Patients w/ #AtrialFibrillation [#AFIB] K. Okumura MD, et al. @NEJM @JWatch https://t.co/any1ZJzwnI [subscription] #Stroke #Embolism https://t.co/ddt3TXmunC
-
ENVISAGE-TAVI AF findings from #ESCCongress2021 show #edoxaban was non-inferior to vitamin K antagonist in preventing adverse clinical events in post-TAVR #AFib patients: https://t.co/dTL53HVpv0